HomeBCAX • NASDAQ
Bicara Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 41.79M | 171.81% |
Net income | -36.85M | -194.58% |
Net profit margin | — | — |
Earnings per share | -0.68 | — |
EBITDA | -41.77M | -171.92% |
Effective tax rate | -0.20% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 462.07M | 100.51% |
Total assets | 478.08M | — |
Total liabilities | 19.12M | — |
Total equity | 458.96M | — |
Shares outstanding | 54.54M | — |
Price to book | 1.15 | — |
Return on assets | -21.15% | — |
Return on capital | -21.94% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -36.85M | -194.58% |
Cash from operations | -28.11M | -92.68% |
Cash from investing | — | — |
Cash from financing | 460.00K | 235.77% |
Net change in cash | -27.65M | -92.09% |
Free cash flow | -17.37M | — |
Previous close
$9.67
Day range
$9.29 - $9.83
Year range
$7.80 - $28.08
Market cap
518.91M USD
Avg Volume
1.13M
P/E ratio
0.67
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
55
